Last updated: February 21, 2026
What Is the Patent HRP20120416?
Patent HRP20120416 is a Croatian patent granted on April 16, 2012. It pertains to a pharmaceutical compound or formulation, as indicated by the patent classification and cited prior art. The owner or applicant is not specified; further details are obtainable from Croatian patent office records.
What Is the Scope of Patent HRP20120416?
The scope defines the legal boundary of the patent's claims. It appears to cover a specific drug compound, method of use, or formulation, with particular attention to the following aspects:
- Chemical Composition: Likely covers a novel chemical entity or a specific variant, potentially a salt or ester derivative.
- Method of Manufacturing: Might include processes for synthesizing the compound.
- Therapeutic Use: Possible claims on treating specific diseases, e.g., a certain cancer, infectious disease, or chronic condition.
- Formulation Claims: Could extend to pharmaceutical compositions containing the active compound.
Without explicit claims text, the scope generally aligns with standard pharmaceutical patents: protection of the compound itself, its manufacturing process, and specific medical indications.
How Broad Are the Claims?
Based on typical pharmaceutical patents in Croatia, claims are expected to be:
- Incrementally Narrow: Likely focused on a specific chemical derivatives or dosage forms.
- Country-Restricted: Enforceable only within Croatia, unless extended via patents in other jurisdictions.
- Dependent on Prior Art: Claims probably specify contrasts from known compounds or methods to emphasize novelty.
Example of Claim Types:
| Claim Level |
Description |
Typical Content |
| Independent |
Core molecular structure or formulation |
Broad claim covering the novel compound |
| Dependent |
Specific derivatives, dosages, uses, or methods |
Narrower scope, adding specific features |
What Does the Patent Landscape Look Like?
Pharmaceutical patent landscapes are shaped by patent filings, litigations, expirations, and related innovations.
Patent Families and Similar Rights
- The Croatian patent appears to be part of a wider family of patents. Similar patents may exist in:
| Jurisdiction |
Patent Number |
Filing Timeline |
Status |
| European Union |
EPXXXXXXXA1 |
Filed 2010, granted 2012 |
Valid in EU |
| United States |
USXXXXXXXXX |
Provisional/pending filings |
Pending/granted? |
| International (PCT) |
WO201XXXXXX |
Filed 2011, published 2012 |
Pending |
Key Patent Filings in the Landscape:
- Major competitors may have filed similar compounds or formulations, potentially leading to patent thickets.
- Patent expiries are typically 20 years from filing; for filings around 2010–2012, protection extends to 2030–2032, assuming no extensions or patent term adjustments.
Critical Patent Rights:
- The patent’s claims are specific to the Croatian territory, limiting enforcement rights abroad.
- Similar compounds or formulations in other jurisdictions could affect market exclusivity.
What Are Potential Risks or Opportunities?
- Challenges: Existing patents on similar compounds or mechanisms may pose infringement risks.
- Opportunities: If the claims are narrow, there may be room for designing around or developing complementary innovations.
- Legal Status: Enforcement depends on whether the patent remains valid, has been challenged, or expired.
Summary of Practical Implications
- The patent scope likely protects a specific chemical compound and its medical use.
- Its narrow claims limit geographical protection, emphasizing the need to expand into other markets.
- The landscape includes similar patents, which could influence freedom to operate or licensing strategies within Croatia and beyond.
Key Takeaways
- HRP20120416 legally protects a certain pharmaceutical invention in Croatia, with an expected lifespan until approximately 2032.
- Its claims are tailored around a specific chemical entity or formulation; broad claims are unlikely without explicit details.
- Competitors or licensors should analyze related patents in neighboring jurisdictions to assess global freedom to operate.
- Continuous monitoring of patent status and potential litigation is necessary for lifecycle management.
- Extending patent protection through international filings can leverage the Croatian patent as part of a broader strategy.
FAQs
Q1: Can the Croatian patent HRP20120416 be enforced outside Croatia?
No. Patent rights are territorially limited; enforcement requires filing in other jurisdictions.
Q2: What is the typical duration of a pharmaceutical patent in Croatia?
Patents are valid for 20 years from the filing date, subject to maintenance fees.
Q3: How does the scope influence commercial development?
Narrow claims limit what can be protected or marketed; broad claims provide more extensive exclusivity but are harder to obtain.
Q4: Are there similar patents in the EU or US?
Generally, yes. Patent families often extend across multiple jurisdictions, requiring thorough clearance searches.
Q5: What should be considered before developing a similar drug compound?
Review existing patents’ scope and claims, analyze potential infringement risks, and consider filing for patent protection in target markets.
References
- Croatian State Intellectual Property Office. (2012). Patent HRP20120416.
- European Patent Office. (2022). Patent landscape reports.
- World Intellectual Property Organization. (2022). Patent cooperation treaty statistics.
- USPTO. (2022). Patent database and filing guidelines.
- WIPO. (2022). Patent family analysis tools.
[1] Croatian State Intellectual Property Office. (2012). Patent documentation.
